Addictions Neuroclinical Assessment: A Neuroscience-Based Framework for Addictive Disorders

Biological Psychiatry

Volumn 80, Issue 3, 2016, Pages 179-189

  Kwako, Laura E ^a   Momenan, Reza ^a   Litten, Raye Z ^a   Koob, George F ^a   Goldman, David ^a  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

Author keywords

Addiction; Assessment; Diagnosis; Neuroimaging; Nosology; Substance use

Indexed keywords

ADDICTION; ADDICTIONS NEUROCLINICAL ASSESSMENT; CLINICAL ASSESSMENT; CLINICAL PRACTICE; DISEASE CLASSIFICATION; EMOTIONALITY; EXECUTIVE FUNCTION; GENE IDENTIFICATION; HUMAN; MENTAL DISEASE ASSESSMENT; MENTAL PERFORMANCE; NEUROIMAGING; NEUROLOGIC EXAMINATION; NEUROSCIENCE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TREATMENT RESPONSE; CLASSIFICATION; DIAGNOSTIC IMAGING; EMOTION; MOTIVATION; NEUROPSYCHOLOGICAL TEST; PSYCHOLOGICAL MODEL; PSYCHOLOGY; SUBSTANCE-RELATED DISORDERS;

BEHAVIOR, ADDICTIVE; EMOTIONS; EXECUTIVE FUNCTION; HUMANS; MODELS, PSYCHOLOGICAL; MOTIVATION; NEUROIMAGING; NEUROPSYCHOLOGICAL TESTS; SUBSTANCE-RELATED DISORDERS;

EID: 84954288334     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2015.10.024     Document Type: Review

References (147)

1. 1 Jellinek, E.M., Alcoholism, a genus and some of its species. Can Med Assoc J 83 (1960), 1341–1345.
2. 2 Leggio, L., Kenna, G.A., Fenton, M., Bonenfant, E., Swift, R.M., Typologies of alcohol dependence. From Jellinek to genetics and beyond. Neuropsychol Rev 19 (2009), 115–129.
3. 3 Ball, S.A., Carroll, K.M., Babor, T.F., Rounsaville, B.J., Subtypes of cocaine abusers: Support for a type A-type B distinction. J Consult Clin Psychol 63 (1995), 115–124.
4. 4 Falck, R.S., Wang, J., Carlson, R.G., Crack cocaine trajectories among users in a midwestern American city. Addiction 102 (2007), 1421–1431.
5. 5 Sun, J., Bi, J., Chan, G., Oslin, D., Farrer, L., Gelernter, J., Kranzler, H.R., Improved methods to identify stable, highly heritable subtypes of opioid use and related behaviors. Addict Behav 37 (2012), 1138–1144.
6. 6 Ramo, D.E., Grov, C., Delucchi, K., Kelly, B.C., Parsons, J.T., Typology of club drug use among young adults recruited using time-space sampling. Drug Alcohol Depend 107 (2010), 119–127.
7. 7 Babor, T.F., Webb, C., Burleson, J.A., Kaminer, Y., Subtypes for classifying adolescents with marijuana use disorders: Construct validity and clinical implications. Addiction 97:suppl 1 (2002), 58–69.
8. 8 Wittchen, H.U., Behrendt, S., Hofler, M., Perkonigg, A., Rehm, J., Lieb, R., Beesdo, K., A typology of cannabis-related problems among individuals with repeated illegal drug use in the first three decades of life: Evidence for heterogeneity and different treatment needs. Drug Alcohol Depend 102 (2009), 151–157.
9. 9 Koob, G.F., Le Moal, M., Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 24 (2001), 97–129.
10. 10 Goldman, D., Oroszi, G., Ducci, F., The genetics of addictions: Uncovering the genes. Nat Rev Genet 6 (2005), 521–532.
11. 11 Volpicelli, J.R., Alterman, A.I., Hayashida, M., O'Brien, C.P., Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry 49 (1992), 876–880.
12. 12 American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed., 2013, American Psychiatric Publishing, Incorporated, Washington, DC.
13. 13 Lobbestael, J., Leurgans, M., Arntz, A., Inter-rater reliability of the Structured Clinical Interview for DSM-IV Axis I Disorders (SCID I) and Axis II Disorders (SCID II). Clin Psychol Psychother 18 (2011), 75–79.
14. 14 Nelson, C.B., Rehm, J., Ustun, T.B., Grant, B., Chatterji, S., Factor structures for DSM-IV substance disorder criteria endorsed by alcohol, cannabis, cocaine and opiate users: Results from the WHO reliability and validity study. Addiction 94 (1999), 843–855.
15. 15 Charney, D.S., Barlow, D.H., Botteron, K., Cohen, J.D., Goldman, D., Gur, R.E., et al. Neuroscience research agenda to guide development of a pathophysiologically based classification system. Kupfer, D.J., First, M.B., Regier, D.A., (eds.) A Research Agenda for DSM-V, 2002, American Psychiatric Association, Arlington, VA, 31–83.
16. 16 Vogel, C.L., Cobleigh, M.A., Tripathy, D., Gutheil, J.C., Harris, L.N., Fehrenbacher, L., et al. Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer. J Clin Oncol 20 (2002), 719–726.
17. 17 Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P.A., Harshman, K., Tavtigian, S., et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 266 (1994), 66–71.
18. 18 Kadden, R., Carbonari, J., Litt, M., Tonigan, S., Zweben, A., Matching alcoholism treatments to client heterogeneity: Project MATCH three-year drinking outcomes. Alcohol Clin Exp Res 22 (1998), 1300–1311.
19. 19 Witkiewitz, K., Marlatt, A., Behavioral therapy across the spectrum. Alcohol Res Health 33 (2011), 313–319.
20. 20 Ray, L.A., Hutchison, K.E., MacKillop, J., Miranda, R. Jr, Audette, A., Swift, R., Monti, P.M., Effects of naltrexone during the descending limb of the blood alcohol curve. Am J Addict 17 (2008), 257–264.
21. 21 Swift, R.M., Whelihan, W., Kuznetsov, O., Buongiorno, G., Hsuing, H., Naltrexone-induced alterations in human ethanol intoxication. Am J Psychiatry 151 (1994), 1463–1467.
22. 22 De Witte, P., Littleton, J., Parot, P., Koob, G., Neuroprotective and abstinence-promoting effects of acamprosate. CNS Drugs 19 (2005), 517–537.
23. 23 Scott, L., Figgitt, D., Keam, S., Waugh, J., Acamprosate. CNS Drugs 19 (2005), 445–464.
24. 24 Spanagel, R., Putzke, J., Stefferl, A., Schöbitz, B., Zieglgänsberger, W., Acamprosate and alcohol: II. Effects on alcohol withdrawal in the rat. Eur J Pharmacol 305 (1996), 45–50.
25. 25 Cloninger, C.R., Neurogenetic adaptive mechanisms in alcoholism. Science 236 (1987), 410–416.
26. 26 Insel, T., Cuthbert, B., Garvey, M., Heinssen, R., Pine, D.S., Quinn, K., et al. Research domain criteria (RDoC): Toward a new classification framework for research on mental disorders. Am J Psychiatry 167 (2010), 748–751.
27. 27 Litten, R.Z., Ryan, M.L., Falk, D.E., Reilly, M., Fertig, J.B., Koob, G.F., Heterogeneity of alcohol use disorder: Understanding mechanisms to advance personalized treatment. Alcohol Clin Exp Res 39 (2015), 579–584.
28. 28 Substance Abuse and Mental Health Services Administration (2013): 2013 National Survey on Drug Use and Health. Washington, DC: U.S. Department of Health and Human Services.
29. 29 Lorains, F.K., Cowlishaw, S., Thomas, S.A., Prevalence of comorbid disorders in problem and pathological gambling: Systematic review and meta-analysis of population surveys. Addiction 106 (2011), 490–498.
30. 30 Grant, B.F., Goldstein, R.B., Saha, T.D., Chou, S.P., Jung, J., Zhang, H., et al. Epidemiology of DSM-5 alcohol use disorder: Results from the National Epidemiologic Survey on Alcohol and Related Conditions III. JAMA Psychiatry 72 (2015), 757–766.
31. 31 Slutske, W.S., Natural recovery and treatment-seeking in pathological gambling: Results of two U.S. National Surveys. Am J Psychiatry 163 (2006), 297–302.
32. 32 Mark, T.L., Kassed, C.A., Vandivort-Warren, R., Levit, K.R., Kranzler, H.R., Alcohol and opioid dependence medications: Prescription trends, overall and by physician specialty. Drug Alcohol Depend 99 (2009), 345–349.
33. 33 Goldstein, R.Z., Volkow, N.D., Drug addiction and its underlying neurobiological basis: Neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry 159 (2002), 1642–1652.
34. 34 Schumann, G., Loth, E., Banaschewski, T., Barbot, A., Barker, G., Buchel, C., et al. The IMAGEN study: Reinforcement-related behaviour in normal brain function and psychopathology. Mol Psychiatry 15 (2010), 1128–1139.
35. 35 Hamilton, C.M., Strader, L.C., Pratt, J.G., Maiese, D., Hendershot, T., Kwok, R.K., et al. The PhenX Toolkit: Get the most from your measures. Am J Epidemiol 174 (2011), 253–260.
36. 36 Carter, C.S., Barch, D.M., Cognitive neuroscience-based approaches to measuring and improving treatment effects on cognition in schizophrenia: The CNTRICS initiative. Schizophr Bull 33 (2007), 1131–1137.
37. 37 Carpenter, W.T., RDoC and DSM-5: What's the fuss?. Schizophr Bull 39 (2013), 945–946.
38. 38 Casey, B.J., Oliveri, M.E., Insel, T., A neurodevelopmental perspective on the research domain criteria (RDoC) framework. Biol Psychiatry 76 (2014), 350–353.
39. 39 Cuthbert, B.N., Insel, T.R., Toward the future of psychiatric diagnosis: The seven pillars of RDoC. BMC Med, 11, 2013, 126.
40. 40 Insel, T.R., The NIMH Research Domain Criteria (RDoC) Project: Precision medicine for psychiatry. Am J Psychiatry 171 (2014), 395–397.
41. 41 Goldstein, R.Z., Volkow, N.D., Dysfunction of the prefrontal cortex in addiction: Neuroimaging findings and clinical implications. Nat Rev Neurosci 12 (2011), 652–669.
42. 42 Nymberg, C., Jia, T., Ruggeri, B., Schumann, G., Analytical strategies for large imaging genetic datasets: Experiences from the IMAGEN study. Ann N Y Acad Sci 1282 (2013), 92–106.
43. 43 Thyreau, B., Schwartz, Y., Thirion, B., Frouin, V., Loth, E., Vollstadt-Klein, S., et al. Very large fMRI study using the IMAGEN database: Sensitivity-specificity and population effect modeling in relation to the underlying anatomy. Neuroimage 61 (2012), 295–303.
44. 44 Loth, E., Poline, J.B., Thyreau, B., Jia, T., Tao, C., Lourdusamy, A., et al. Oxytocin receptor genotype modulates ventral striatal activity to social cues and response to stressful life events. Biol Psychiatry 76 (2014), 367–376.
45. 45 Muller, K.U., Gan, G., Banaschewski, T., Barker, G.J., Bokde, A.L., Buchel, C., et al. No differences in ventral striatum responsivity between adolescents with a positive family history of alcoholism and controls. Addict Biol 20 (2014), 534–545.
46. 46 Nymberg, C., Banaschewski, T., Bokde, A.L., Buchel, C., Conrod, P., Flor, H., et al. DRD2/ANKK1 polymorphism modulates the effect of ventral striatal activation on working memory performance. Neuropsychopharmacology 39 (2014), 2357–2365.
47. 47 Tzschoppe, J., Nees, F., Banaschewski, T., Barker, G.J., Buchel, C., Conrod, P.J., et al. Aversive learning in adolescents: Modulation by amygdala-prefrontal and amygdala-hippocampal connectivity and neuroticism. Neuropsychopharmacology 39 (2014), 875–884.
48. 48 Whelan, R., Watts, R., Orr, C.A., Althoff, R.R., Artiges, E., Banaschewski, T., et al. Neuropsychosocial profiles of current and future adolescent alcohol misusers. Nature 512 (2014), 185–189.
49. 49 McCarty, C.A., Huggins, W., Aiello, A.E., Bilder, R.M., Hariri, A., Jernigan, T.L., et al. PhenX RISING: Real world implementation and sharing of PhenX measures. BMC Med Genomics, 7, 2014, 16.
50. 50 Hendershot, T., Pan, H., Haines, J., Harlan, W.R., Junkins, H.A., Ramos, E.M., et al. Using the PhenX Toolkit to add standard measures to a study. Curr Protoc Hum Genet Chapter 1:Unit1, 2011, 21.
51. 51 Hitz, M.M., Conway, P.G., Palcher, J.A., McCarty, C.A., Using PhenX toolkit measures and other tools to assess urban/rural differences in health behaviors: Recruitment methods and outcomes. BMC Res Notes, 7, 2014, 847.
52. 52 McCarty, C.A., Berg, R., Rottscheit, C.M., Waudby, C.J., Kitchner, T., Brilliant, M., Ritchie, M.D., Validation of PhenX measures in the personalized medicine research project for use in gene/environment studies. BMC Med Genomics, 7, 2014, 3.
53. 53 Pan, H., Tryka, K.A., Vreeman, D.J., Huggins, W., Phillips, M.J., Mehta, J.P., et al. Using PhenX measures to identify opportunities for cross-study analysis. Hum Mutat 33 (2012), 849–857.
54. 54 Conway, K.P., Vullo, G.C., Kennedy, A.P., Finger, M.S., Agrawal, A., Bjork, J.M., et al. Data compatibility in the addiction sciences: An examination of measure commonality. Drug Alcohol Depend 141 (2014), 153–158.
55. 55 Barch, D.M., Berman, M.G., Engle, R., Jones, J.H., Jonides, J., Macdonald, A. 3rd, et al. CNTRICS final task selection: Working memory. Schizophr Bull 35 (2009), 136–152.
56. 56 Barch, D.M., Moore, H., Nee, D.E., Manoach, D.S., Luck, S.J., CNTRICS imaging biomarkers selection: Working memory. Schizophr Bull 38 (2012), 43–52.
57. 57 Carter, C.S., Barch, D.M., Gur, R., Gur, R., Pinkham, A., Ochsner, K., CNTRICS final task selection: Social cognitive and affective neuroscience-based measures. Schizophr Bull 35 (2009), 153–162.
58. 58 Ragland, J.D., Cohen, N.J., Cools, R., Frank, M.J., Hannula, D.E., Ranganath, C., CNTRICS imaging biomarkers final task selection: Long-term memory and reinforcement learning. Schizophr Bull 38 (2012), 62–72.
59. 59 Koob, G.F., Le Moal, M., Drug abuse: Hedonic homeostatic dysregulation. Science 278 (1997), 52–58.
60. 60 Romanczuk-Seiferth, N., van den Brink, W., Goudriaan, A.E., From symptoms to neurobiology: Pathological gambling in the light of the new classification in DSM-5. Neuropsychobiology 70 (2014), 95–102.
61. 61 Bickel, W.K., Jarmolowicz, D.P., Mueller, E.T., Gatchalian, K.M., McClure, S.M., Are executive function and impulsivity antipodes? A conceptual reconstruction with special reference to addiction. Psychopharmacology (Berl) 221 (2012), 361–387.
62. 62 Thoma, R.J., Monnig, M.A., Lysne, P.A., Ruhl, D.A., Pommy, J.A., Bogenschutz, M., et al. Adolescent substance abuse: The effects of alcohol and marijuana on neuropsychological performance. Alcohol Clin Exp Res 35 (2011), 39–46.
63. 63 Kalapatapu, R.K., Vadhan, N.P., Rubin, E., Bedi, G., Cheng, W.Y., Sullivan, M.A., Foltin, R.W., A pilot study of neurocognitive function in older and younger cocaine abusers and controls. Am J Addict 20 (2011), 228–239.
64. 64 Yakir, A., Rigbi, A., Kanyas, K., Pollak, Y., Kahana, G., Karni, O., et al. Why do young women smoke? III. Attention and impulsivity as neurocognitive predisposing factors. Eur Neuropsychopharmacol 17 (2007), 339–351.
65. 65 Pau, C.W., Lee, T.M., Shui-fun, F.C., The impact of heroin on frontal executive functions. Arch Clin Neuropsychol 17 (2002), 663–670.
66. 66 Salo, R., Nordahl, T.E., Moore, C., Waters, C., Natsuaki, Y., Galloway, G.P., et al. A dissociation in attentional control: Evidence from methamphetamine dependence. Biol Psychiatry 57 (2005), 310–313.
67. 67 Roca, M., Torralva, T., López, P., Cetkovich, M., Clark, L., Manes, F., Executive functions in pathologic gamblers selected in an ecologic setting. Cogn Behav Neurol 21 (2008), 1–4.
68. 68 Ersche, K.D., Clark, L., London, M., Robbins, T.W., Sahakian, B.J., Profile of executive and memory function associated with amphetamine and opiate dependence. Neuropsychopharmacology 31 (2006), 1036–1047.
69. 69 Bolla, K.I., Brown, K., Eldreth, D., Tate, K., Cadet, J., Dose-related neurocognitive effects of marijuana use. Neurology 59 (2002), 1337–1343.
70. 70 Bolla, K.I., Rothman, R., Cadet, J.L., Dose-related neurobehavioral effects of chronic cocaine use. J Neuropsychiatry Clin Neurosci 11 (1999), 361–369.
71. 71 Ornstein, T.J., Iddon, J.L., Baldacchino, A.M., Sahakian, B.J., London, M., Everitt, B.J., Robbins, T.W., Profiles of cognitive dysfunction in chronic amphetamine and heroin abusers. Neuropsychopharmacology 23 (2000), 113–126.
72. 72 Petry, N.M., Delay discounting of money and alcohol in actively using alcoholics, currently abstinent alcoholics, and controls. Psychopharmacology (Berl) 154 (2001), 243–250.
73. 73 Johnson, M.W., Bickel, W.K., Baker, F., Moderate drug use and delay discounting: A comparison of heavy, light, and never smokers. Exp Clin Psychopharmacol, 15, 2007, 187.
74. 74 Bindra, D., A motivational view of learning, performance, and behavior modification. Psychol Rev 81 (1974), 199–213.
75. 75 Robbins, T.W., Relationship between reward-enhancing and stereotypical effects of psychomotor stimulant drugs. Nature 264 (1976), 57–59.
76. 76 Robinson, T.E., Berridge, K.C., The neural basis of drug craving: An incentive-sensitization theory of addiction. Brain Res Brain Res Rev 18 (1993), 247–291.
77. 77 Schultz, W., Dopamine neurons and their role in reward mechanisms. Curr Opin Neurobiol 7 (1997), 191–197.
78. 78 Jasinska, A.J., Stein, E.A., Kaiser, J., Naumer, M.J., Yalachkov, Y., Factors modulating neural reactivity to drug cues in addiction: A survey of human neuroimaging studies. Neurosci Biobehav Rev 38 (2014), 1–16.
79. 79 Muller-Oehring, E.M., Jung, Y.C., Sullivan, E.V., Hawkes, W.C., Pfefferbaum, A., Schulte, T., Midbrain-driven emotion and reward processing in alcoholism. Neuropsychopharmacology 38 (2013), 1844–1853.
80. 80 Schacht, J.P., Anton, R.F., Myrick, H., Functional neuroimaging studies of alcohol cue reactivity: A quantitative meta-analysis and systematic review. Addict Biol 18 (2013), 121–133.
81. 81 Gilman, J.M., Smith, A.R., Ramchandani, V.A., Momenan, R., Hommer, D.W., The effect of intravenous alcohol on the neural correlates of risky decision making in healthy social drinkers. Addict Biol 17 (2012), 465–478.
82. 82 Roh, S., Matsushita, S., Hara, S., Maesato, H., Matsui, T., Suzuki, G., et al. Role of GABRA2 in moderating subjective responses to alcohol. Alcohol Clin Exp Res 35 (2011), 400–407.
83. 83 Jokisch, D., Roser, P., Juckel, G., Daum, I., Bellebaum, C., Impairments in learning by monetary rewards and alcohol-associated rewards in detoxified alcoholic patients. Alcohol Clin Exp Res 38 (2014), 1947–1954.
84. 84 Grusser, S.M., Wrase, J., Klein, S., Hermann, D., Smolka, M.N., Ruf, M., et al. Cue-induced activation of the striatum and medial prefrontal cortex is associated with subsequent relapse in abstinent alcoholics. Psychopharmacology (Berl) 175 (2004), 296–302.
85. 85 Sinha, R., Fox, H.C., Hong, K.I., Hansen, J., Tuit, K., Kreek, M.J., Effects of adrenal sensitivity, stress- and cue-induced craving, and anxiety on subsequent alcohol relapse and treatment outcomes. Arch Gen Psychiatry 68 (2011), 942–952.
86. 86 Sinha, R., Li, C.S., Imaging stress- and cue-induced drug and alcohol craving: Association with relapse and clinical implications. Drug Alcohol Rev 26 (2007), 25–31.
87. 87 Field, M., Munafo, M.R., Franken, I.H., A meta-analytic investigation of the relationship between attentional bias and subjective craving in substance abuse. Psychol Bull 135 (2009), 589–607.
88. 88 Marissen, M.A., Franken, I.H., Waters, A.J., Blanken, P., van den Brink, W., Hendriks, V.M., Attentional bias predicts heroin relapse following treatment. Addiction 101 (2006), 1306–1312.
89. 89 Vollstadt-Klein, S., Loeber, S., Richter, A., Kirsch, M., Bach, P., von der Goltz, C., et al. Validating incentive salience with functional magnetic resonance imaging: Association between mesolimbic cue reactivity and attentional bias in alcohol-dependent patients. Addict Biol 17 (2012), 807–816.
90. 90 Everitt, B.J., Belin, D., Economidou, D., Pelloux, Y., Dalley, J.W., Robbins, T.W., Review. Neural mechanisms underlying the vulnerability to develop compulsive drug-seeking habits and addiction. Philos Trans R Soc Lond B Biol Sci 363 (2008), 3125–3135.
91. 91 Lovinger, D.M., Neurotransmitter roles in synaptic modulation, plasticity and learning in the dorsal striatum. Neuropharmacology 58 (2010), 951–961.
92. 92 Heilig, M., Thorsell, A., Sommer, W.H., Hansson, A.C., Ramchandani, V.A., George, D.T., et al. Translating the neuroscience of alcoholism into clinical treatments: From blocking the buzz to curing the blues. Neurosci Biobehav Rev 35 (2010), 334–344.
93. 93 Sinha, R., Fox, H.C., Hong, K.A., Bergquist, K., Bhagwagar, Z., Siedlarz, K.M., Enhanced negative emotion and alcohol craving, and altered physiological responses following stress and cue exposure in alcohol dependent individuals. Neuropsychopharmacology 34 (2009), 1198–1208.
94. 94 Hatzigiakoumis, D.S., Martinotti, G., Giannantonio, M.D., Janiri, L., Anhedonia and substance dependence: Clinical correlates and treatment options. Front Psychiatry, 2, 2011, 10.
95. 95 Heinz, A., Schmidt, L.G., Reischies, F.M., Anhedonia in schizophrenic, depressed, or alcohol-dependent patients—neurobiological correlates. Pharmacopsychiatry 27:suppl 1 (1994), 7–10.
96. 96 Salo, R., Ursu, S., Buonocore, M.H., Leamon, M.H., Carter, C., Impaired prefrontal cortical function and disrupted adaptive cognitive control in methamphetamine abusers: A functional magnetic resonance imaging study. Biol Psychiatry 65 (2009), 706–709.
97. 97 Salo, R., Nordahl, T.E., Galloway, G.P., Moore, C.D., Waters, C., Leamon, M.H., Drug abstinence and cognitive control in methamphetamine-dependent individuals. J Subst Abuse Treat 37 (2009), 292–297.
98. 98 Martinotti, G., Nicola, M.D., Reina, D., Andreoli, S., Foca, F., Cunniff, A., et al. Alcohol protracted withdrawal syndrome: The role of anhedonia. Subst Use Misuse 43 (2008), 271–284.
99. 99 Janiri, L., Martinotti, G., Dario, T., Reina, D., Paparello, F., Pozzi, G., et al. Anhedonia and substance-related symptoms in detoxified substance-dependent subjects: A correlation study. Neuropsychobiology 52 (2005), 37–44.
100. 100 Garavan, H., Hester, R., The role of cognitive control in cocaine dependence. Neuropsychol Rev 17 (2007), 337–345.
101. 101 Snaith, R.P., Hamilton, M., Morley, S., Humayan, A., Hargreaves, D., Trigwell, P., A scale for the assessment of hedonic tone the Snaith-Hamilton Pleasure Scale. Br J Psychiatry 167 (1995), 99–103.
102. 102 Koob, G.F., Buck, C.L., Cohen, A., Edwards, S., Park, P.E., Schlosburg, J.E., et al. Addiction as a stress surfeit disorder. Neuropharmacology 76 (2014), 370–382.
103. 103 Wong, C.C.Y., Mill, J., Fernandes, C., Drugs and addiction: An introduction to epigenetics. Addiction 106 (2011), 480–489.
104. 104 Brooks, P.J., Goldman, D., Li, T.K., Alleles of alcohol and acetaldehyde metabolism genes modulate susceptibility to oesophageal cancer from alcohol consumption. Hum Genomics 3 (2009), 103–105.
105. 105 Heilig, M., Goldman, D., Berrettini, W., O'Brien, C.P., Pharmacogenetic approaches to the treatment of alcohol addiction. Nat Rev Neurosci 12 (2011), 670–684.
106. 106 Jones, J.D., Comer, S.D., Kranzler, H.R., The pharmacogenetics of alcohol use disorder. Alcohol Clin Exp Res 39 (2015), 391–402.
107. 107 Anton, R.F., Oroszi, G., O'Malley, S., Couper, D., Swift, R., Pettinati, H., Goldman, D., An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: Results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study. Arch Gen Psychiatry 65 (2008), 135–144.
108. 108 Ramchandani, V.A., Umhau, J., Pavon, F.J., Ruiz-Velasco, V., Margas, W., Sun, H., et al. A genetic determinant of the striatal dopamine response to alcohol in men. Mol Psychiatry 16 (2011), 809–817.
109. 109 Oslin, D.W., Leong, S.H., Lynch, K.G., Berrettini, W., O'Brien, C.P., Gordon, A.J., Rukstalis, M., Naltrexone vs placebo for the treatment of alcohol dependence: A randomized clinical trial. JAMA Psychiatry 72 (2015), 430–437.
110. 110 Volkow, N.D., Chang, L., Wang, G.-J., Fowler, J.S., Ding, Y.-S., Sedler, M., et al. Low level of brain dopamine D2 receptors in methamphetamine abusers: Association with metabolism in the orbitofrontal cortex. Am J Psychiatry 158 (2001), 2015–2021.
111. 111 Volkow, N.D., Wang, G.-J., Telang, F., Fowler, J.S., Logan, J., Childress, A.-R., et al. Cocaine cues and dopamine in dorsal striatum: Mechanism of craving in cocaine addiction. J Neurosci 26 (2006), 6583–6588.
112. 112 Zhu, X., Cortes, C.R., Mathur, K., Tomasi, D., Momenan, R., Model-free functional connectivity and impulsivity correlates of alcohol dependence: A resting-state study [published online ahead of print June 3]. Addict Biol, 2015.
113. 113 Filbey, F.M., Ray, L., Smolen, A., Claus, E.D., Audette, A., Hutchison, K.E., Differential neural response to alcohol priming and alcohol taste cues is associated with DRD4 VNTR and OPRM1 genotypes. Alcohol Clin Exp Res 32 (2008), 1113–1123.
114. 114 Hong, L.E., Hodgkinson, C.A., Yang, Y., Sampath, H., Ross, T.J., Buchholz, B., et al. A genetically modulated, intrinsic cingulate circuit supports human nicotine addiction. Proc Natl Acad Sci U S A 107 (2010), 13509–13514.
115. 115 Zhu, X.H., Sarah, G., Dutta, N., Schwandt, M., Jia, Y.a.n., Hodgkinson, C.A., et al. VMAT1 influences withdrawal severity and resting-state functional connectivity in alcohol dependence. Hum Brain Mapp 36 (2015), 4808–4818.
116. 116 McLellan, A.T., Kushner, H., Metzger, D., Peters, R., Smith, I., Grissom, G., et al. The fifth edition of the Addiction Severity Index. J Subst Abuse Treat 9 (1992), 199–213.
117. 117 Sobell, L.C., Sobell, M.B., Timeline follow-back: A technique for assessing self-reported ethanol consumption. Allen, J., Litten, R.Z., (eds.) Measuring Alcohol Consumption: Psychosocial and Biological Methods, 1992, Humana Press, Totowa, NJ, 41–72.
118. 118 Costa, P.T. Jr, McCrae, R.R., NEO PI-R. Professional Manual Odessa. 1992, Psychological Assessment Resources, FL.
119. 119 Buysse, D.J., Reynolds, C.F., Monk, T.H., Berman, S.R., Kupfer, D.J., The Pittsburgh Sleep Quality Index: A new instrument for psychiatric practice and research. Psychiatry Res 28 (1989), 193–213.
120. 120 Stokes, J.P., Wilson, D.G., The inventory of socially supportive behaviors: Dimensionality, prediction, and gender differences. Am J Community Psychol 12 (1984), 53–69.
121. 121 Koob, G.F., Volkow, N.D., Neurocircuitry of addiction. Neuropsychopharmacology 35 (2010), 217–238.
122. 122 Schuckit, M.A., Subjective responses to alcohol in sons of alcoholics and control subjects. Arch Gen Psychiatry 41 (1984), 879–884.
123. 123 Loeber, S., Duka, T., Acute alcohol impairs conditioning of a behavioural reward-seeking response and inhibitory control processes—implications for addictive disorders. Addiction 104 (2009), 2013–2022.
124. 124 Somerville, L.H., Hare, T., Casey, B., Frontostriatal maturation predicts cognitive control failure to appetitive cues in adolescents. J Cogn Neurosci 23 (2011), 2123–2134.
125. 125 Riccio, C.A., Reynolds, C.R., Lowe, P., Moore, J.J., The continuous performance test: A window on the neural substrates for attention?. Arch Clin Neuropsychol 17 (2002), 235–272.
126. 126 Krikorian, R., Bartok, J., Gay, N., Tower of London procedure: A standard method and developmental data. J Clin Exp Neuropsychol 16 (1994), 840–850.
127. 127 Heaton, R.K., Wisconsin Card Sorting Test: Computer Version 2. 1993, Psychological Assessment Resources, Odessa, FL.
128. 128 Bickel, W.K., Odum, A.L., Madden, G.J., Impulsivity and cigarette smoking: Delay discounting in current, never, and ex-smokers. Psychopharmacology (Berl) 146 (1999), 447–454.
129. 129 Owen, A.M., McMillan, K.M., Laird, A.R., Bullmore, E., N-back working memory paradigm: A meta-analysis of normative functional neuroimaging studies. Hum Brain Mapp 25 (2005), 46–59.
130. 130 Phillips, L.D., Edwards, W., Conservatism in a simple probability inference task. J Exp Psychol, 72, 1966, 346.
131. 131 Patton, J.H., Stanford, M.S., Factor structure of the Barratt impulsiveness scale. J Clin Psychol 51 (1995), 768–774.
132. 132 Heuer, K., Rinck, M., Becker, E.S., Avoidance of emotional facial expressions in social anxiety: The Approach-Avoidance Task. Behav Res Ther 45 (2007), 2990–3001.
133. 133 Williams, K.D., Jarvis, B., Cyberball: A program for use in research on interpersonal ostracism and acceptance. Behav Res Methods 38 (2006), 174–180.
134. 134 Kirschbaum, C., Klauer, T., Filipp, S.-H., Hellhammer, D.H., Sex-specific effects of social support on cortisol and subjective responses to acute psychological stress. Psychosom Med 57 (1995), 23–31.
135. 135 Lovallo, W., The cold pressor test and autonomic function: A review and integration. Psychophysiology 12 (1975), 268–282.
136. 136 Patterson, F., Jepson, C., Loughead, J., Perkins, K., Strasser, A.A., Siegel, S., et al. Working memory deficits predict short-term smoking resumption following brief abstinence. Drug Alcohol Depend 106 (2010), 61–64.
137. 137 Sebold, M., Deserno, L., Nebe, S., Schad, D.J., Garbusow, M., Hägele, C., et al. Model-based and model-free decisions in alcohol dependence. Neuropsychobiology 70 (2014), 122–131.
138. 138 Beck, A.T., Steer, R.A., Carbin, M.G., Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation. Clin Psychol Rev 8 (1988), 77–100.
139. 139 Steer, R.A., Beck, A.T., Beck Anxiety Inventory. Zalaquett, C.P., Wood, R.J., (eds.) Evaluating Stress: A Book of Resources, 1997, Scarecrow Press, Lantham, MD, 23–40.
140. 140 Fawcett, J., Clark, D.C., Scheftner, W.A., Gibbons, R.D., Assessing anhedonia in psychiatric patients: The pleasure scale. Arch Gen Psychiatry 40 (1983), 79–84.
141. 141 Bagby, R.M., Parker, J.D., Taylor, G.J., The twenty-item Toronto Alexithymia Scale—I. Item selection and cross-validation of the factor structure. J Psychosom Res 38 (1994), 23–32.
142. 142 Bernstein, D.P., Stein, J.A., Newcomb, M.D., Walker, E., Pogge, D., Ahluvalia, T., et al. Development and validation of a brief screening version of the Childhood Trauma Questionnaire. Child Abuse Negl 27 (2003), 169–190.
143. 143 Hariri, A.R., Tessitore, A., Mattay, V.S., Fera, F., Weinberger, D.R., The amygdala response to emotional stimuli: A comparison of faces and scenes. Neuroimage 17 (2002), 317–323.
144. 144 Moeller, S.J., Maloney, T., Parvaz, M.A., Dunning, J.P., Alia-Klein, N., Woicik, P.A., et al. Enhanced choice for viewing cocaine pictures in cocaine addiction. Biol Psychiatry 66 (2009), 169–176.
145. 145 Ehrman, R.N., Robbins, S.J., Bromwell, M.A., Lankford, M.E., Monterosso, J.R., O'Brien, C.P., Comparing attentional bias to smoking cues in current smokers, former smokers, and non-smokers using a dot-probe task. Drug Alcohol Depend 67 (2002), 185–191.
146. 146 Anton, R.F., Moak, D.H., Latham, P., The Obsessive Compulsive Drinking Scale: A self-rated instrument for the quantification of thoughts about alcohol and drinking behavior. Alcohol Clin Exp Res 19 (1995), 92–99.
147. 147 Knutson, B., Adams, C.M., Fong, G.W., Hommer, D., Anticipation of increasing monetary reward selectively recruits nucleus accumbens. J Neurosci, 21, 2001, RC159.